Spruce Biosciences, Inc.
SPRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $11 | $16 | $26 | $39 |
| + Debt | $1 | $2 | $2 | $3 |
| Enterprise Value | – | -$15 | -$23 | -$36 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | – | – | – | 100% |
| EBITDA | -$8 | -$2 | -$14 | -$23 |
| % Margin | – | – | – | -3,370.7% |
| Net Income | -$8 | -$2 | -$14 | -$24 |
| % Margin | – | – | – | -3,380.1% |
| EPS Diluted | -14.58 | -3.41 | -24 | -43.5 |
| % Growth | -327.6% | 85.8% | 44.8% | – |
| Operating Cash Flow | -$5 | -$9 | -$13 | -$21 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5 | -$9 | -$13 | -$21 |